{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:21:12Z","timestamp":1793017272752,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute for Health and Care Research (NIHR) Health Protection Research Unit (HPRU) in Behavioural Science and Evaluation"},{"DOI":"10.13039\/501100022244","name":"National Institute for Health Research Applied Research Collaboration West","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022244","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bristol Health Partners Drug and Alcohol Health Integration Team"},{"name":"Bristol, North Somerset and South Gloucestershire Integrated Care System"},{"name":"South West Public Health Training Scheme"},{"name":"University of Bristol RED fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Skin and soft tissue infections (SSTI) among people who inject drugs (PWID) are a public health concern. This study aimed to co-produce and assess the acceptability and feasibility of a behavioural intervention to prevent SSTI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Person-Based Approach (PBA) was followed which involves: (i) collating and analysing evidence; (ii) developing guiding principles; (iii) a behavioural analysis; (iv) logic model development; and (v) designing and refining intervention materials. Co-production activities with target group representatives and key collaborators obtained feedback on the intervention\u00a0which was used to refine its\u00a0design and content. The intervention, harm reduction advice cards to support conversation between service provider and PWID and resources to support safer injecting practice, was piloted with 13 PWID by four service providers in Bristol and evaluated using a mixed-methods approach. Semi-structured interviews were conducted with 11 PWID and four service providers. Questionnaires completed by all PWID recorded demographic characteristics, SSTI, drug use and treatment history. Interviews were analysed thematically and questionnaires were\u00a0analysed descriptively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Published literature highlighted structural barriers to safer injecting practices, such as access to hygienic injecting environments and injecting practices associated with SSTI included: limited handwashing\/injection-site swabbing and use of too much acidifier to dissolve drugs. Co-production activities and the literature indicated vein care and minimisation of pain as PWID priorities. The importance of service provider\u2013client relationships and non-stigmatising delivery was highlighted through the co-production work. Providing practical resources was identified as important to address environmental constraints to safer injecting practices. Most participants receiving the intervention were White British, male, had a history of SSTI and on average were 43.6\u00a0years old and had injected for 22.7\u00a0years. The intervention was well-received by PWID and service providers. Intervention content and materials given out to support harm reduction were viewed positively. The intervention appeared to support reflections on and intentions to change injecting behaviours, though barriers to safer injecting practice remained prominent.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The PBA ensured the intervention aligned to the priorities of PWID. It was viewed as acceptable and mostly feasible to PWID and service providers and has transferability promise. Further implementation alongside broader harm reduction interventions is needed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-023-00823-9","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T10:02:31Z","timestamp":1692698551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development, acceptability and feasibility of a personalised, behavioural intervention to prevent bacterial skin and soft tissue infections among people who inject drugs: a mixed-methods Person-Based Approach study"],"prefix":"10.1186","volume":"20","author":[{"given":"Joanna","family":"Kesten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Hussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bayliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Erswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Telfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Mellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgie","family":"MacArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"823_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","volume":"171","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39\u201349.","journal-title":"Drug Alcohol Depend"},{"key":"823_CR2","doi-asserted-by":"crossref","first-page":"109494","DOI":"10.1016\/j.drugalcdep.2022.109494","volume":"236","author":"S Colledge-Frisby","year":"2022","unstructured":"Colledge-Frisby S, Jones N, Larney S, Peacock A, Lewer D, Brothers TD, et al. The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: a retrospective data linkage study. Drug Alcohol Depend. 2022;236:109494.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"823_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QCO.0000000000000902","volume":"36","author":"F Allaw","year":"2023","unstructured":"Allaw F, Zakhour J, Kanj SS. Community-acquired skin and soft-tissue infections in people who inject drugs. Curr Opin Infect Dis. 2023;36(2):67\u201373.","journal-title":"Curr Opin Infect Dis"},{"issue":"7","key":"823_CR4","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/add.15283","volume":"116","author":"R Robertson","year":"2021","unstructured":"Robertson R, Broers B, Harris M. Injecting drug use, the skin and vasculature. Addiction. 2021;116(7):1914\u201324.","journal-title":"Addiction"},{"issue":"Suppl 1","key":"823_CR5","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S0924-8579(09)70541-2","volume":"34","author":"MS Dryden","year":"2009","unstructured":"Dryden MS. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents. 2009;34(Suppl 1):S2\u20137.","journal-title":"Int J Antimicrob Agents"},{"issue":"1\u20132","key":"823_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2008.08.016","volume":"100","author":"R Dwyer","year":"2009","unstructured":"Dwyer R, Topp L, Maher L, Power R, Hellard M, Walsh N, et al. Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users. Drug Alcohol Depend. 2009;100(1\u20132):9\u201316.","journal-title":"Drug Alcohol Depend"},{"key":"823_CR7","unstructured":"Croxford S, Emanuel E, Njoroge J, Slater L, Ibitoye A, Ijaz S, et al. Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2021 report Health protection report 2021. Contract No.: Number 13"},{"issue":"8","key":"823_CR8","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3201\/eid2308.170439","volume":"23","author":"D Lewer","year":"2017","unstructured":"Lewer D, Harris M, Hope V. Opiate injection-associated skin, soft tissue, and vascular infections, England, UK, 1997\u20132016. Emerg Infect Dis. 2017;23(8):1400\u20133.","journal-title":"Emerg Infect Dis"},{"key":"823_CR9","doi-asserted-by":"crossref","first-page":"108080","DOI":"10.1016\/j.drugalcdep.2020.108080","volume":"213","author":"J Doran","year":"2020","unstructured":"Doran J, Harris M, Hope VD, Wright T, Edmundson C, Sinka K, et al. Factors associated with skin and soft tissue infections among people who inject drugs in the United Kingdom: a comparative examination of data from two surveys. Drug Alcohol Depend. 2020;213:108080.","journal-title":"Drug Alcohol Depend"},{"key":"823_CR10","doi-asserted-by":"crossref","first-page":"113183","DOI":"10.1016\/j.socscimed.2020.113183","volume":"260","author":"M Harris","year":"2020","unstructured":"Harris M. Normalised pain and severe health care delay among people who inject drugs in London: adapting cultural safety principles to promote care. Soc Sci Med. 2020;260:113183.","journal-title":"Soc Sci Med"},{"key":"823_CR11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.drugpo.2018.09.001","volume":"65","author":"K Dunleavy","year":"2019","unstructured":"Dunleavy K, Hope V, Roy K, Taylor A. The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: a qualitative study. Int J Drug Policy. 2019;65:65\u201372.","journal-title":"Int J Drug Policy"},{"key":"823_CR12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugalcdep.2017.01.020","volume":"174","author":"K Dunleavy","year":"2017","unstructured":"Dunleavy K, Munro A, Roy K, Hutchinson S, Palmateer N, Knox T, et al. Association between harm reduction intervention uptake and skin and soft tissue infections among people who inject drugs. Drug Alcohol Depend. 2017;174:91\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"823_CR13","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2011.03749.x","volume":"107","author":"M Harris","year":"2012","unstructured":"Harris M, Rhodes T. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs. Addiction. 2012;107(6):1090\u20136.","journal-title":"Addiction"},{"issue":"1","key":"823_CR14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/add.13089","volume":"111","author":"P Roux","year":"2016","unstructured":"Roux P, Le Gall J-M, Debrus M, Protopopescu C, Ndiaye K, Demoulin B, et al. Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS\u2013AERLI intervention study. Addiction. 2016;111(1):94\u2013106.","journal-title":"Addiction"},{"key":"823_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2018.07.028","volume":"192","author":"S Mezaache","year":"2018","unstructured":"Mezaache S, Protopopescu C, Debrus M, Morel S, Mora M, Suzan-Monti M, et al. Changes in supervised drug-injecting practices following a community-based educational intervention: a longitudinal analysis. Drug Alcohol Depend. 2018;192:1\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"823_CR16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12879-021-05895-1","volume":"21","author":"S Mezaache","year":"2021","unstructured":"Mezaache S, Briand-Madrid L, Rahni L, Poireau J, Branchu F, Moudachirou K, et al. A two-component intervention to improve hand hygiene practices and promote alcohol-based hand rub use among people who inject drugs: a mixed-methods evaluation. BMC Infect Dis. 2021;21(1):211.","journal-title":"BMC Infect Dis"},{"key":"823_CR17","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/add.15236","volume":"116","author":"MD Stein","year":"2020","unstructured":"Stein MD, Phillips KT, Herman DS, Keosaian J, Stewart C, Anderson BJ, et al. Skin-cleaning among hospitalized people who inject drugs: a randomized controlled trial. Addiction. 2020;116:1122\u201330.","journal-title":"Addiction"},{"key":"823_CR18","doi-asserted-by":"crossref","first-page":"108646","DOI":"10.1016\/j.drugalcdep.2021.108646","volume":"221","author":"KT Phillips","year":"2021","unstructured":"Phillips KT, Stewart C, Anderson BJ, Liebschutz JM, Herman DS, Stein MD. A randomized controlled trial of a brief behavioral intervention to reduce skin and soft tissue infections among people who inject drugs. Drug Alcohol Depend. 2021;221:108646.","journal-title":"Drug Alcohol Depend"},{"key":"823_CR19","unstructured":"Bristol City Council and Bristol NSaSGCCG. JSNA Health and Wellbeing Profile 2020\/21. Substance Misuse. 2021."},{"key":"823_CR20","unstructured":"Bristol Drugs Project. Written evidence submitted by The Bristol Drugs Project (DRU0022) 2022. https:\/\/committees.parliament.uk\/writtenevidence\/107299\/pdf\/."},{"key":"823_CR21","unstructured":"Design Council. What is the framework for innovation? Design Council's evolved Double Diamond Design Council, UK. 2021."},{"key":"823_CR22","unstructured":"DiPS. Reducing Harm from invasive bacterial infections among people who inject drugs in and around Bristol. Report of a Design Council and Local Government Association 'Design in the Public Sector' Programme. In: Process Pi, editor. 2019."},{"issue":"1","key":"823_CR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40814-015-0033-z","volume":"1","author":"L Yardley","year":"2015","unstructured":"Yardley L, Ainsworth B, Arden-Close E, Muller I. The person-based approach to enhancing the acceptability and feasibility of interventions. Pilot Feasibility Stud. 2015;1(1):37.","journal-title":"Pilot Feasibility Stud"},{"issue":"1","key":"823_CR24","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.2196\/jmir.4055","volume":"17","author":"L Yardley","year":"2015","unstructured":"Yardley L, Morrison L, Bradbury K, Muller I. The person-based approach to intervention development: application to digital health-related behavior change interventions. J Med Internet Res. 2015;17(1):e30.","journal-title":"J Med Internet Res"},{"key":"823_CR25","unstructured":"Yardley L, Ainsworth B, Muller I, Denison-Day J, Morton K, Bradbury K, Morrison L, Payne L, Essery R, Miller S, Pollet S. Person based approach 2023. https:\/\/www.personbasedapproach.org\/index.html."},{"issue":"1","key":"823_CR26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","volume":"6","author":"S Michie","year":"2011","unstructured":"Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42.","journal-title":"Implement. Sci."},{"issue":"4","key":"823_CR27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1464-0597.2008.00341.x","volume":"57","author":"S Michie","year":"2008","unstructured":"Michie S, Johnston M, Francis J, Hardeman W, Eccles M. From theory to intervention: mapping theoretically derived behavioural determinants to behaviour change techniques. J Appl Psychol. 2008;57(4):660\u201380.","journal-title":"J Appl Psychol"},{"key":"823_CR28","doi-asserted-by":"crossref","first-page":"561320","DOI":"10.1155\/2014\/561320","volume":"2014","author":"K Bradbury","year":"2014","unstructured":"Bradbury K, Watts S, Arden-Close E, Yardley L, Lewith G. Developing digital interventions: a methodological guide. Evid Based Complement Altern Med. 2014;2014:561320.","journal-title":"Evid Based Complement Altern Med"},{"key":"823_CR29","unstructured":"Spencer L, Ritchie J, Ormston R, O'Connor W, Barnard M. Analysis: principles and processes. In: Ritchie J, Lewis J, McNaughton Nicolls C, Ormston R, editors. Qualitative Research Practice A guide for social science students and researchers. Second ed. London Sage; 2014."},{"issue":"5","key":"823_CR30","first-page":"595","volume":"107","author":"D Vlahov","year":"1992","unstructured":"Vlahov D, Sullivan M, Astemborski J, Nelson KE. Bacterial infections and skin cleaning prior to injection among intravenous drug users. Public Health Rep. 1992;107(5):595\u20138.","journal-title":"Public Health Rep"},{"issue":"1","key":"823_CR31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/320879","volume":"33","author":"EL Murphy","year":"2001","unstructured":"Murphy EL, DeVita D, Liu H, Vittinghoff E, Leung P, Ciccarone DH, et al. Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis. 2001;33(1):35\u201340.","journal-title":"Clin Infect Dis"},{"key":"823_CR32","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2334-8-120","volume":"8","author":"V Hope","year":"2008","unstructured":"Hope V, Kimber J, Vickerman P, Hickman M, Ncube F. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis. 2008;8:120.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"823_CR33","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.drugpo.2015.04.009","volume":"26","author":"D Ciccarone","year":"2015","unstructured":"Ciccarone D, Harris M. Fire in the vein: Heroin acidity and its proximal effect on users\u2019 health. Int J Drug Policy. 2015;26(11):1103\u201310.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"823_CR34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.drugpo.2012.06.007","volume":"24","author":"M Harris","year":"2013","unstructured":"Harris M. The \u2018do-it-yourself\u2019 New Zealand injecting scene: implications for harm reduction. Int J Drug Policy. 2013;24(4):281\u20133.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"823_CR35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12954-019-0330-6","volume":"16","author":"M Harris","year":"2019","unstructured":"Harris M, Scott J, Wright T, Brathwaite R, Ciccarone D, Hope V. Injecting-related health harms and overuse of acidifiers among people who inject heroin and crack cocaine in London: a mixed-methods study. Harm Reduct J. 2019;16(1):60.","journal-title":"Harm Reduct J"},{"issue":"1","key":"823_CR36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12954-020-00369-0","volume":"17","author":"M Harris","year":"2020","unstructured":"Harris M, Scott J, Hope V, Wright T, McGowan C, Ciccarone D. Navigating environmental constraints to injection preparation: the use of saliva and other alternatives to sterile water among unstably housed PWID in London. Harm Reduct J. 2020;17(1):24.","journal-title":"Harm Reduct J"},{"key":"823_CR37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/1471-2458-8-405","volume":"8","author":"E Lloyd-Smith","year":"2008","unstructured":"Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JSG, Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health. 2008;8:405.","journal-title":"BMC Public Health."},{"issue":"10","key":"823_CR38","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1017\/S0950268810000324","volume":"138","author":"VD Hope","year":"2010","unstructured":"Hope VD, Marongiu A, Parry JV, Ncube F. The extent of injection site infection in injecting drug users: findings from a national surveillance study. Epidemiol Infect. 2010;138(10):1510\u20138.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"823_CR39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(00)00161-7","volume":"62","author":"S Darke","year":"2001","unstructured":"Darke S, Ross J, Kaye S. Physical injecting sites among injecting drug users in Sydney, Australia. Drug Alcohol Depend. 2001;62(1):77\u201382.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"823_CR40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1363459316660859","volume":"22","author":"J Rance","year":"2018","unstructured":"Rance J, Rhodes T, Fraser S, Bryant J, Treloar C. Practices of partnership: Negotiated safety among couples who inject drugs. Health. 2018;22(1):3\u201319.","journal-title":"Health"},{"issue":"1","key":"823_CR41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2524.2005.00552.x","volume":"13","author":"NM Wright","year":"2005","unstructured":"Wright NM, Tompkins CN, Jones L. Exploring risk perception and behaviour of homeless injecting drug users diagnosed with hepatitis C. Health Soc Care Community. 2005;13(1):75\u201383.","journal-title":"Health Soc Care Community"},{"key":"823_CR42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugpo.2015.11.003","volume":"28","author":"VD Hope","year":"2016","unstructured":"Hope VD, Parry JV, Ncube F, Hickman M. Not in the vein: \u201cmissed hits\u201d, subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom. Int J Drug Policy. 2016;28:83\u201390.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"823_CR43","first-page":"37e45","volume":"18","author":"T Kerr","year":"2007","unstructured":"Kerr T, Small W, Moore D, Wood E. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver\u2019s safer injection facility. Int J Drug Policy. 2007;18(1):37e45.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"823_CR44","doi-asserted-by":"crossref","first-page":"307e324","DOI":"10.1080\/13698575.2012.680950","volume":"14","author":"W Small","year":"2012","unstructured":"Small W, Moore D, Shoveller J, Wood E, Kerr T. Perceptions of risk and safety within injection settings: Injection drug users\u2019 reasons for attending a supervised injecting facility in Vancouver, Canada. Health Risk Soc 2012;14(4):307e324.","journal-title":"Health Risk Soc"},{"issue":"106","key":"823_CR45","first-page":"151","volume":"2014","author":"R McNeil","year":"1982","unstructured":"McNeil R, Small W. \u201cSafer environment interventions\u201d: a qualitative synthesis of the experiences and perceptions of people who inject drugs. Soc Sci Med. 1982;2014(106):151\u20138.","journal-title":"Soc Sci Med"},{"issue":"3","key":"823_CR46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","volume":"20","author":"T Rhodes","year":"2009","unstructured":"Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20(3):193\u2013201.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"823_CR47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/j.2051-5545.2009.tb00218.x","volume":"8","author":"PW Corrigan","year":"2009","unstructured":"Corrigan PW, Larson JE, R\u00fcsch N. Self-stigma and the \u201cwhy try\u201d effect: impact on life goals and evidence-based practices. World Psychiatry. 2009;8(2):75\u201381.","journal-title":"World Psychiatry"},{"key":"823_CR48","unstructured":"Exchange Supplies. Injecting Tips #1: Bacterial infections 2021. https:\/\/www.exchangesupplies.org\/shopdisp_Injecting_tips_leaflet_bacterial_infections_colour.php"},{"issue":"1","key":"823_CR49","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugpo.2007.01.005","volume":"19","author":"C Treloar","year":"2008","unstructured":"Treloar C, Laybutt B, Jauncey M, van Beek I, Lodge M, Malpas G, et al. Broadening discussions of \u201csafe\u201d in hepatitis C prevention: a close-up of swabbing in an analysis of video recordings of injecting practice. Int J Drug Policy. 2008;19(1):59\u201365.","journal-title":"Int J Drug Policy"},{"key":"823_CR50","unstructured":"The Exchange Supplies website: https:\/\/training.exchangesupplies.org\/bdpreact-stage_1. Accessed 24 Jan 2022."},{"key":"823_CR51","unstructured":"Exchange Supplies. Exchange Training 2021. https:\/\/training.exchangesupplies.org\/."},{"key":"823_CR52","unstructured":"Public Health England. Wound aware: a resource for commissioners and providers of drug services: GOV.UK; 2021. https:\/\/www.gov.uk\/government\/publications\/wound-aware-a-resource-for-drug-services\/wound-aware-a-resource-for-commissioners-and-providers-of-drug-services."},{"key":"823_CR53","doi-asserted-by":"crossref","unstructured":"Lewer D, Brothers TD, Croxford S, Desai M, Emanuel E, Harris M, et al. Opioid injection-associated bacterial infections in England, 2002\u20132021: a time series analysis of seasonal variation and the impact of coronavirus disease 2019. Clin Infect Dis. 2023.","DOI":"10.1093\/cid\/ciad144"},{"issue":"3","key":"823_CR54","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/S2468-2667(22)00038-X","volume":"7","author":"A Holland","year":"2022","unstructured":"Holland A, Harris M, Hickman M, Lewer D, Shorter GW, Horsley J, et al. Overdose prevention centres in the UK. Lancet Public Health. 2022;7(3):e196\u20137.","journal-title":"Lancet Public Health"},{"issue":"12","key":"823_CR55","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1111\/add.14747","volume":"114","author":"JP Caulkins","year":"2019","unstructured":"Caulkins JP, Pardo B, Kilmer B. Supervised consumption sites: a nuanced assessment of the causal evidence. Addiction. 2019;114(12):2109\u201315.","journal-title":"Addiction"},{"key":"823_CR56","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/add.15236","volume":"116","author":"MD Stein","year":"2020","unstructured":"Stein MD, Phillips KT, Herman DS, Keosaian J, Stewart C, Anderson BJ, et al. Skin cleaning among hospitalized persons who inject drugs: a randomized controlled trial. Addiction. 2020;116:1122\u201330.","journal-title":"Addiction"},{"key":"823_CR57","unstructured":"London School of Hygeine and Tropical Medicine. iHOST 2023. https:\/\/www.lshtm.ac.uk\/research\/centres-projects-groups\/ihost."},{"key":"823_CR58","unstructured":"Black C. Review of drugs part two: prevention, treatment, and recovery. 2021."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00823-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-023-00823-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-023-00823-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T11:22:10Z","timestamp":1700565730000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-023-00823-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1186\/s12954-023-00823-9","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"2 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research approvals from the University of Bristol\u2019s Faculty of Health Sciences Research Ethics Committee (reference: 108304) were obtained to undertake the study overall (which included a pilot phase and interviews with participants and service providers). Co-production that informed intervention development was classified as Patient and Public Involvement. Therefore, the University of Bristol\u2019s Faculty of Health Sciences Research Ethics Committee has waived consent for this study. However, good research practice was followed throughout. Prior to the co-production activities, the researcher explained the purpose and procedures of the activity, and explicitly asked the respondent if they understood everything, and wanted to contribute. They were also informed they\u00a0could stop the activity at any time. All methods were carried out in accordance with relevant guidelines and regulations. Pilot intervention participants consented to anonymised direct quotes being used in publications resulting from the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}